588 related articles for article (PubMed ID: 19025933)
1. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
[TBL] [Abstract][Full Text] [Related]
2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C.
Berenguer M; Palau A; Fernandez A; Benlloch S; Aguilera V; Prieto M; Rayón JM; Berenguer J
Liver Transpl; 2006 Jul; 12(7):1067-76. PubMed ID: 16622844
[TBL] [Abstract][Full Text] [Related]
4. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
Sharma P; Marrero JA; Fontana RJ; Greenson JK; Conjeevaram H; Su GL; Askari F; Sullivan P; Lok AS
Liver Transpl; 2007 Aug; 13(8):1100-8. PubMed ID: 17377914
[TBL] [Abstract][Full Text] [Related]
5. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.
Berenguer M; Aguilera V; Prieto M; Ortiz C; Rodríguez M; Gentili F; Risalde B; Rubin A; Cañada R; Palau A; Rayón JM
Liver Transpl; 2009 Jul; 15(7):738-46. PubMed ID: 19562707
[TBL] [Abstract][Full Text] [Related]
6. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
[TBL] [Abstract][Full Text] [Related]
7. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis C virus infection in thalassemia.
Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
[TBL] [Abstract][Full Text] [Related]
9. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
[TBL] [Abstract][Full Text] [Related]
11. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Kobayashi S; Takeda T; Enomoto M; Tamori A; Kawada N; Habu D; Sakaguchi H; Kuroda T; Kioka K; Kim SR; Kanno T; Ueda T; Hirano M; Fujimoto S; Jomura H; Nishiguchi S; Seki S
Liver Int; 2007 Mar; 27(2):186-91. PubMed ID: 17311612
[TBL] [Abstract][Full Text] [Related]
12. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
[TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
15. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S
Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285
[TBL] [Abstract][Full Text] [Related]
17. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
Arjal RR; Burton JR; Villamil F; Rosen HR
Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060
[TBL] [Abstract][Full Text] [Related]
18. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.
Hanouneh IA; Feldstein AE; Lopez R; Yerian L; Pillai A; Zein CO; Zein NN
Clin Gastroenterol Hepatol; 2008 May; 6(5):584-9. PubMed ID: 18455698
[TBL] [Abstract][Full Text] [Related]
20. An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy.
Cesaro S; Bortolotti F; Petris MG; Brugiolo A; Guido M; Carli M
Pediatr Blood Cancer; 2010 Jul; 55(1):108-12. PubMed ID: 20127849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
